Enlivex Therapeutics Ltd

NASDAQ:ENLV   3:59:42 PM EDT
12.61
-0.53 (-4.03%)
Products, Regulatory, Other Pre-Announcement

Enlivex Reports Positive Allocetra Trial Results In Covid-19 Patients

Published: 10/01/2020 10:36 GMT
Enlivex Therapeutics Ltd (ENLV) - Enlivex Reports Positive Allocetra Trial Results in Covid-19 Patients in Severe/critical Condition.
Enlivex Therapeutics Ltd - There Were No Reported Severe Adverse Events in Clinical Trial.
Enlivex Therapeutics Ltd - Therapy Was Well-tolerated.
Enlivex Therapeutics Ltd - Phase Iib Trial is Expected to Commence in Q4 of 2020.
Enlivex - Determined to Shift Recruitment of Additional Patients Into Larger Phase Ii Clinical Trial of Covid-19 Patients in Severe/critical Condition.
Enlivex - Initial Positive Results in Sepsis Patients Treated With Allocetra Consistent With Those Observed in Covid-19 Patients in Severe, Critical Condition.